NASAL INSULIN OUTPATIENT STUDY IN TYPE-I DIABETES by Holman, R, Steemson, J

TWICE-DAILY SUBCUTANEOUS HUMAN PROINSULIN PROVIDES A SATISFACTORY BASAL INSULIN SUPPLEMENT IN TYPE-2 (NON-INSULIN-DEPENDENT) DIABETIC-PATIENTS by Holman, R, Steemson, J, Turner, R

Sulphonylurea failure in type 2 diabetes: treatment with a basal insulin supplement. by Holman, R, Steemson, J, Turner, R

Post-prandial glycaemic reduction by an alpha-glucosidase inhibitor in type 2 diabetic patients with therapeutically attained basal normoglycaemia. by Holman, R, Steemson, J, Turner, R

No glycemic benefit from guar administration in NIDDM. by Holman, R, Steemson, J, Darling, P, Turner, R

HUMAN ULTRALENTE INSULIN by Holman, R, Steemson, J, Darling, P, Turner, R

LACK OF BENEFIT FROM ACUTE ELEVATION OF PLASMA GLIBENCLAMIDE LEVELS BEFORE MEALS by Turner, R, Steemson, J, Burnett, M, Holman, R

LACK OF BENEFIT FROM GUAR ADMINISTRATION IN WELL CONTROLLED NON-INSULIN-DEPENDENT DIABETIC-PATIENTS by Holman, R, Steemson, J, Darling, P, Turner, R

TIMING OF NASAL INSULIN DELIVERY IN TYPE-I DIABETES by Holman, R, Steemson, J, Carter, R, Levy, J

Human ultralente insulin. by Holman, R, Steemson, J, Darling, P, Reeves, W, Turner, R

Rapid restoration of normoglycaemia using intravenous insulin boluses. by Dunnett, J, Steemson, J, Sear, J, Turner, R, Holman, R

Pen-sized digital 30-second blood glucose meter. by Matthews, DR, Holman, R, Bown, E, Steemson, J, Watson, A, Hughes, S, Scott, D

Capillary and venous blood glucose measurements using a direct glucose-sensing meter. by Matthews, D, Burton, S, Bown, E, Chusney, G, Dornan, T, Gale, E, McKinnon, G, Steemson, J

2-YEAR PROSPECTIVE-STUDY OF IMPROVED DIABETIC CONTROL IN INSULIN-DEPENDENT DIABETIC-PATIENTS WITH BACKGROUND RETINOPATHY by Holman, R, Dornan, T, Mayonwhite, V, Steemson, J, Peckar, C, Howardwilliams, J, Knight, A, Hockaday, T, Bron, A, Turner, R

2-YEAR RANDOMIZED PROSPECTIVE-STUDY OF IMPROVED DIABETIC CONTROL IN TYPE-1 (INSULIN-DEPENDENT) DIABETIC-PATIENTS WITH RETINOPATHY - PREVENTION OF DETERIORATION OF NERVE AND RENAL-F... by Holman, R, Dornan, T, Mayonwhite, V, Ting, A, Howardwilliams, J, Peckar, C, Jenkins, L, Steemson, J, Smith, B, Barbour, D, Mcpherson, K, Knight, A, Hockaday, T, Bron, A, Turner, R

Prevention of deterioration of renal and sensory-nerve function by more intensive management of insulin-dependent diabetic patients. A two-year randomised prospective study. by Holman, R, Dornan, T, Mayon-White, V, Howard-Williams, J, Orde-Peckar, C, Jenkins, L, Steemson, J, Rolfe, R, Smith, B, Barbour, D, McPherson, K, Poon, P, Rizza, C, Mann, J, Knight, A, Bron, A, Turner, R

Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39. UK Prospective Diabetes Study Group. by Stearne, MR, Palmer, S, Hammersley, MS, Franklin, S, Spivey, R, Levy, J, Tidy, C, Bell, N, Steemson, J, Barrow, B, Coster, R, Waring, K, Nolan, L, Truscott, E, Walravens, N, Cook, B, Lampard, H, Merle, C, Parker, P, McVittie, J, Draisey, I, Murchison, L, Brunt, A, Williams, M, Pearson, D

Cost effectiveness analysis of improved blood pressure control in hypertensive patients with type 2 diabetes: UKPDS 40 by Stearne, MR, Palmer, S, Hammersley, MS, Franklin, S, Spivey, R, Levy, J, Tidy, C, Bell, N, Steemson, J, Barrow, B, Coster, R, Waring, K, Nolan, L, Truscott, E, Walravens, N, Cook, L, Lampard, H, Merle, C, Parker, P, McVittie, J, Draisey, I, Murchison, L, Brunt, A, Williams, M, Pearson, D

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. by Stearne, MR, Palmer, S, Hammersley, MS, Franklin, S, Spivey, R, Levy, J, Tidy, C, Bell, N, Steemson, J, Barrow, B, Coster, R, Waring, K, Nolan, J, Truscott, E, Walravens, N, Cook, L, Lampard, H, Merle, C, Parker, P, McVittie, J, Draisey, I, Murchison, L, Brunt, A, Williams, M, Pearson, D